We Recommend That You Do Not Throw Away Any Leftover Pills Which Were Included in the Recalls. If Possible, Store Them In A Safe Place For Potential Testing And Proof Of Purchase.

Sartan Class Action Lawsuit

The law firms of Charney Lawyers PC and Rice Harbut Elliot LLP have commenced a national class action on behalf of all persons in Canada who purchased or ingested one or more of the Sartan products which have been recalled.

Health Canada recalls various "sartans" due to azido impurity.

An impurity, (5-(4'-(azidomethyl)-[1,1'-biphenyl]-2yl)-1H-tetrazole, which is referred to as an “azido impurity”, has been detected in certain sartan products for sale in Canada. The azido impurity is considered a ‘mutagen’, meaning it can cause a change in the DNA of a cell. Mutagens may increase the risk of cancer.

Irbesartan, losartan and valsartan are all prescription angiotensin receptor blocker drugs used to treat patients with high blood pressure and prevent heart attacks and stroke.  They are also used for patients with heart failure or in those who have had a recent heart attack.

On January 1, 2021, Health Canada issued a product safety recall for irbesartan-HCTZ.

On May 21, 2021, Health Canada issued a product safety recall for Sandoz-Valsaratan.

On May 26, 2021, Health Canada issued a further product safety recall for Sanis Valsartan.

Finally, on May 31, 2021, Health Canada issued a further product safety recall for multiple lots of irbesartans, losartans and valsartans.

Recalls and safety alerts from Health Canada

Irbesartan-HCTZ (2021-01-12), Health Canada - Last updated January 1, 2021 

Sanis Valsartan (2021-05-21), Health Canada – Last Updated May 26, 2021 

Sandoz-Valsartan Product Recall (2021-05-21), Health Canada – Last updated May 21, 2021 

Multiple lots of irbesartan, losartan and valsartan due to azido (2021-05-30), Health Canada – Last updated May 31, 2021

Health Canada’s list of Sartan products being recalled in Canada at this time: